2022 Tianjin Medical and Health Clinical Laboratory Center: Measures for the Administration of Clinical Blood Use

& gt>> "65438+10 month" 2022 Tianjin Medical and Health Recruitment Announcement | Publicity Summary (continuously updated)

Blood products have been in short supply in China, so in order to protect blood resources, improve blood safety and medical quality, the state began to implement the Management Measures for Clinical Blood Use in Medical Institutions on August 12.

Blood products are very precious, but they are also prone to adverse reactions of blood transfusion, so it is very important to supervise blood.

First of all, the Ministry of Health is responsible for the supervision and management of clinical blood use in medical institutions across the country; The health administrative department of the local people's government at or above the county level is responsible for the supervision and management of clinical blood use in medical institutions within their respective administrative areas; The health administrative departments of the people's governments of all provinces, autonomous regions and municipalities directly under the Central Government shall set up provincial blood quality control centers to be responsible for the guidance, evaluation and training of the management of clinical blood in medical institutions within their respective jurisdictions.

Secondly, medical institutions should take strengthening the management of clinical blood use as an important part of medical quality management, improve organizational construction, establish and improve post responsibility system, and formulate and implement relevant rules and regulations and technical operating procedures.

In addition, the Ministry of Health has also set up an expert committee on clinical blood use, whose main responsibilities are: to assist in formulating relevant national systems, technical specifications and standards for clinical blood use; Assist in guiding the management and quality evaluation of clinical blood use in China, and promote the improvement of the level of rational clinical blood use; Assist in the investigation and analysis of major safety incidents in clinical blood use, and put forward suggestions for treatment; To undertake other clinical blood management tasks assigned by the Ministry of Health. The Ministry of Health establishes a coordination mechanism to do a good job in the management of clinical blood use, improve the level of rational clinical blood use, and ensure the quality of blood transfusion treatment.

Therefore, it is this interlocking supervision and management that makes us feel at ease in clinical blood transfusion and ensures our health and safety.

In addition to paying attention to blood supervision, the following points need to be done in the process of blood transfusion and preservation of blood products:

1. After receiving the blood from the blood bank, the medical institution should first check the label of the blood bag. The main contents of the check are: the name of the blood station, the number or barcode of blood donation, and the blood type; Blood variety; Date and time of blood collection or date and time of preparation; Validity period and time; Storage conditions. Only blood that meets the relevant national standards and requirements can be put into storage and properly registered; According to different varieties, blood types and blood collection dates (or expiration dates), they are stored in special storage facilities in an orderly manner.

2. During storage, the blood storage facilities of medical institutions should ensure effective operation, the storage temperature of whole blood and red blood cells should be controlled at 2 ~ 6℃, and the storage temperature of platelets should be controlled at 20 ~ 24℃. The blood storage staff shall monitor and record the blood storage temperature for 24 hours, and the blood storage environment shall meet the hygiene standards and requirements.